Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Radiol ; 145: 110047, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34801879

ABSTRACT

PURPOSE: This study investigated the relationship of imaging features of primary tumor and peritumoral VAT on PET/CT with histopathological findings of peritumoral VAT and recurrence-free survival (RFS) in patients with colorectal cancer. METHODS: We retrospectively reviewed 133 patients diagnosed with colorectal cancer who underwent staging FDG PET/CT and received curative surgery. Histogram-based imaging features of primary tumor and peritumoral VAT were extracted from PET/CT images. Based on histopathological analysis of peritumoral VAT, the degree of CD4, CD8, and CD163 cell infiltration and the expression of matrix metalloproteinase-11 and interleukin 6 (IL-6) were graded. Differences in imaging parameters based on the histopathological results and the relationships between imaging features and RFS were assessed. RESULTS: Mean CT-attenuation and SUV of peritumoral VAT showed significant positive correlation with CD163 cell infiltration and IL-6 expression of peritumoral VAT. Univariable survival analysis revealed significant correlation between RFS and the mean CT-attenuation, mean SUV, and first-order SUV entropy of peritumoral VAT (p < 0.05). Multivariable analysis indicated that mean SUV and SUV entropy of peritumoral VAT remained significant predictors of RFS after adjustment for age, sex, and T stage (p < 0.05). CONCLUSION: FDG uptake of peritumoral VAT was significantly associated with inflammatory response in peritumoral VAT and was an independent predictor of RFS in colorectal cancer patients.


Subject(s)
Colorectal Neoplasms , Positron Emission Tomography Computed Tomography , Adipose Tissue , Colorectal Neoplasms/diagnostic imaging , Fluorodeoxyglucose F18 , Humans , Positron-Emission Tomography , Prognosis , Radiopharmaceuticals , Retrospective Studies
2.
Nat Commun ; 8(1): 1456, 2017 11 13.
Article in English | MEDLINE | ID: mdl-29129916

ABSTRACT

While the transcriptional network of human embryonic stem cells (hESCs) has been extensively studied, relatively little is known about how post-transcriptional modulations determine hESC function. RNA-binding proteins play central roles in RNA regulation, including translation and turnover. Here we show that the RNA-binding protein CSDE1 (cold shock domain containing E1) is highly expressed in hESCs to maintain their undifferentiated state and prevent default neural fate. Notably, loss of CSDE1 accelerates neural differentiation and potentiates neurogenesis. Conversely, ectopic expression of CSDE1 impairs neural differentiation. We find that CSDE1 post-transcriptionally modulates core components of multiple regulatory nodes of hESC identity, neuroectoderm commitment and neurogenesis. Among these key pro-neural/neuronal factors, CSDE1 binds fatty acid binding protein 7 (FABP7) and vimentin (VIM) mRNAs, as well as transcripts involved in neuron projection development regulating their stability and translation. Thus, our results uncover CSDE1 as a central post-transcriptional regulator of hESC identity and neurogenesis.


Subject(s)
DNA-Binding Proteins/metabolism , Fatty Acid-Binding Protein 7/metabolism , Human Embryonic Stem Cells/cytology , Neural Plate/embryology , Neurogenesis/genetics , RNA-Binding Proteins/metabolism , Tumor Suppressor Proteins/metabolism , Vimentin/metabolism , Animals , Cell Line , DNA-Binding Proteins/genetics , Fatty Acid-Binding Protein 7/genetics , Gene Expression Regulation/genetics , Humans , Mice , Nervous System/embryology , Neural Plate/cytology , Neural Stem Cells/cytology , Neurogenesis/physiology , RNA Interference , RNA, Messenger/genetics , RNA, Small Interfering/genetics , RNA-Binding Proteins/genetics , Tumor Suppressor Proteins/genetics , Vimentin/genetics
3.
J Craniofac Surg ; 26(3): 956-8, 2015 May.
Article in English | MEDLINE | ID: mdl-25950524
4.
Invest Radiol ; 37(12): 663-71, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12446999

ABSTRACT

RATIONALE AND OBJECTIVES: To determine the dynamic enhancement features of malignant tumor and bacterial abscess in rabbits on magnetic resonance imaging (MRI) after injection of gadolinium mesoporphyrin (gadophrin-2) and to correlate them with histopathologic findings. METHODS: Six VX2 carcinomas and six bacterial abscesses were experimentally induced in either thigh of six rabbits. Dynamic T1-weighted MRI was performed before and 1, 3, 5, 10, 30 minutes and 16, 21, 72 hours after intravenous injection of gadophrin-2 (0.05 mmol/kg). The enhancement ratios of lesions were calculated for each time point. All tumors and abscesses were sectioned along the same plane of MR images for a detailed MRI-histopathologic correlation. RESULTS: In tumors and abscesses, peripheral-rim enhancement appeared on MRI at 1, 3, 5, 10, 30 minutes after injection of gadophrin-2. The lesions showed peripheral enhancement with irregular central enhancement or diffuse enhancement after 16 and 21 hours, and there was diffuse enhancement of the entire lesion after 72 hours. Enhancement ratios in tumor-necrosis mixed area and the pure necrotic area in VX2 carcinoma and the central cavity in bacterial abscess were significantly lower than that in the compact cellular portion in VX2 carcinoma and the wall of abscess at early phase (P < 0.01). On delayed phase MRI, there was no statistical significance in enhancement ratio of three histologic parts of VX2 carcinoma (P > 0.05) and two histologic parts of abscess (P > 0.05). Rapid enhancement at early phase with diminishing signal intensity at delayed phase is indicative of viable compact tumor and delayed strong enhancement is indicative of necrosis. CONCLUSION: It is difficult to distinguish an abscess from a tumor on gadophrin-2 enhanced MRI especially when intratumoral necrosis is prominent. However, the trend and degree of enhancement by gadophrin-2 could be helpful in discrimination between viable tumor and tumor necrosis.


Subject(s)
Abscess/pathology , Carcinoma/pathology , Contrast Media/administration & dosage , Escherichia coli Infections/pathology , Magnetic Resonance Imaging/methods , Mesoporphyrins/administration & dosage , Metalloporphyrins/administration & dosage , Neoplasms, Experimental/pathology , Animals , Contrast Media/pharmacokinetics , Mesoporphyrins/pharmacokinetics , Metalloporphyrins/pharmacokinetics , Neoplasm Transplantation , Rabbits , Thigh
SELECTION OF CITATIONS
SEARCH DETAIL
...